Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute
HAINSWORTH, John D, RUBIN, Mark S, SPIGEL, David R, BOCCIA, Ralph V, RABY, Samuel, QUINN, Raven, GRECO, F. Anthony
Published in Journal of clinical oncology (10.01.2013)
Published in Journal of clinical oncology (10.01.2013)
Get full text
Journal Article
Gene expression profiling for prediction of tissue of origin to direct site-specific therapy in patients with CUP: Treatment outcomes by assay predictive probability
Rubin, Mark S., Greco, Frank A., Boccia, Ralph V., Scola, Michael A., Spigel, David R., Raby, Samuel, Chirwa, Thabiso W., Quinn, Raven, Hainsworth, John D.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients (pts) with carcinoma of unknown primary site (CUP): Results of a prospective Sarah Cannon Research Institute (SCRI) trial
Greco, Frank A., Rubin, Mark S., Boccia, Ralph V., Scola, Michael A., Spigel, David R., Raby, Samuel, Chirwa, Thabiso W., Quinn, Raven, Schnabel, Catherine A., Erlander, Mark G., Hainsworth, John D.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article